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ABSTRACT
Kisspeptin is recognized for its role as the gatekeeper of reproduction in most
mammalian species. However, its role in regulation of reproduction at the ovarian level is poorly
understood in the horse. In this study, ovaries from follicular phase, luteal phase, anestrous
period, and mares treated with ECP-sulpiride were subjected to immunohistochemistry to
characterize kisspeptin-10 (Kp10) and its receptor (Kiss1r) protein expression throughout each
reproductive stage and follicle type. Kisspeptin and receptor staining was detected in all follicle
types (primordial, preantral, and antral) throughout all reproductive stages, as well as oocytes,
corpora lutea, and ovulation fossa. The pattern of Kp10 and Kiss1r staining was affected by
follicle type (P < 0.0001) and reproductive stage (P < 0.001). Kisspeptin-10 immunostaining
intensity was greatest in antral follicles, with no differences (P > 0.05) between reproductive
stages. Kisspeptin receptor immunostaining intensity was greatest in antral follicles, with no
differences between reproductive stages except when comparing follicular phase to anestrous
phase ovaries (P < 0.05). The results of this study indicate kisspeptin and its receptor may have
potential roles in the period leading up to ovulation, as indicated by the intensity of
immunostaining in antral follicles, follicular development, and steroidogenesis.
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CHAPTER 1. INTRODUCTION
Whether they are used for showing, racing, or working, horses have been a part of
American culture and tradition for hundreds of years. The horse industry is considered a
valuable part of the United States economy in that the industry has contributed roughly $122
billion dollars to the U.S. economy, according to the American Horse Council [1]. In order to
produce valuable horses with desirable characteristics, much research has been conducted to
enhance equine breeding management. As a seasonally breeding species, horses have a narrower
window for conception, so manipulation of the breeding season is beneficial. Pharmacological
manipulation is commonplace in equine breeding strategies to induce early cyclicity and
ovulation. In order to effectively manipulate mare reproduction, a complete understanding of the
physiological and endocrine mechanisms that regulate reproduction in the horse is needed.
Kisspeptin is recognized as a central regulator of reproduction by stimulating
hypothalamic gonadotropin releasing hormone (GnRH), but recent discoveries have found that
kisspeptin and its receptor are present in the gonads, as well as other tissues. Extra-hypothalamic
sources and actions of the neuropeptide, kisspeptin, have been described. These discoveries have
provided evidence that kisspeptin has the potential to affect the endocrine activity in the gonads.
A recent study by Petrucci et al. [2] provided the first evidence that kisspeptin and its receptor
are present in the equine testis. Kisspeptin has been localized in ovaries of many species, but has
yet to be determined if kisspeptin and its receptor are present in the equine ovary. Understanding
the physiological role of kisspeptin in equine reproduction, including the ability of the gonads to
respond to kisspeptin, would provide additional insight into the reproductive physiology of the
mare. Recently, our lab has studied the effects of incorporating kisspeptin-10 (Kp10) into an
estradiol benzoate (EB)-sulpiride treatment protocol utilized to induce early ovulation in
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seasonally anestrous mares [3]. The incorporation of Kp10 resulted in more mares ovulating
early compared to mares receiving EB-sulpiride only. Whether the stimulatory effect of Kp10
was at the level of the ovary or the hypothalamic-pituitary (HP) axis could not be determined in
that study.
Further understanding of ovarian physiology in horses has the potential to increase
opportunities for pharmacological manipulation and assisted reproductive techniques. Taniguchi
et al. [4] observed kisspeptin in follicular fluid and found a positive correlation between intrafollicular kisspeptin levels, serum estradiol, and number of oocytes in women undergoing
assisted reproductive technologies. Pursuing to further understand the activity of kisspeptin
beyond the hypothalamus could lead to potential in vitro applications of kisspeptin in embryo
production.
The reproductive physiology of the mare is unique compared to other mammalian species
and provides opportunity for further understanding reproduction in a long-day breeding species,
therefore, the aim of this study is to explore the roles of kisspeptin and its receptor in the equine
ovary by characterizing the immunostaining patterns of kisspeptin and its receptor throughout
follicle types and reproductive stages, and evaluate the pattern of staining in ovaries from
seasonally anestrous mares treated with estradiol and sulpiride to induce early ovulation.
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CHAPTER 2. REVIEW OF LITERATURE
2.1. Hypothalamic-Pituitary-Ovarian Axis
The hypothalamus and the adenohypophysis, also known as the hypothalamic-pituitary
(HP) axis, form a complex neuroendocrine system that is responsible for the maintenance and
regulation of reproduction in most mammalian species. Neurosecretory cells in the
hypothalamus release mostly stimulatory hormones into the hypophysial portal system which
connects the hypothalamus and the adenohypophysis [5,6]. The hypothalamus is considered the
major regulator of reproduction by controlling the synthesis and secretion of the decapeptide,
gonadotropin-releasing hormone (GnRH), into the hypophysial portal system. Pulsatile GnRH
release stimulates the release of gonadotropins, follicle stimulating hormone (FSH) and
luteinizing hormone (LH), from the adenohypophysis [5].
Pulsatile secretion of GnRH varies with season and stage of the reproductive cycle of the
mare and regulates gonadotropin secretion. Pulse amplitude and frequency determine which
gonadotropins are secreted; higher GnRH pulse frequency with low amplitude favors LH
secretion, while lower GnRH pulse frequency with high amplitude favors FSH secretion [6].
The HP axis regulates mare reproduction to coordinate the actions of LH and FSH on the ovary.
Luteinizing hormone is critical to stimulate ovulation, formation of corpora lutea (CL), and
progesterone secretion, and FSH is critical for follicular development, selection, and estradiol
synthesis [7].
Ovarian steroids, estradiol and progesterone, play a role in the regulation of the
hypothalamic-pituitary-ovarian (HPO) axis by providing stimulatory and inhibitory effects on
gonadotropin secretion. Estradiol has a stimulatory effect on LH and an inhibitory effect on
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FSH, while progesterone inhibits LH secretion but does not greatly affect FSH [6]. Estradiol can
exert either positive and/or negative feedback on GnRH depending on concentrations in
circulation.
Gonadal glycoproteins, inhibin and activin, act as additional feedback and feedforward
mediators of FSH, respectively. Inhibin is produced by granulosa cells of growing ovarian
follicles and has a suppressive effect on FSH [5–7]. Increased levels of inhibin suppress FSH
which allows the follicle to become dominant in the presence of increased LH pulse frequency
[7]. Activin is produced by cumulus cells of the growing follicle and acts as stimulator of FSH
secretion at the level of the pituitary. Activin has also be implicated in oocyte maturation,
delaying of luteinization, and ovarian steroidogenesis [6].
2.2. Ovarian Anatomy
The equine ovary is unique compared to other domestic mammalian species in that the
vascular zone, often referred to as the medulla, containing collagenous connective tissue
surrounds the central parenchyma, often referred to as the cortex [6,8]. The cortex contains
developing follicles and luteal structures, including CL and corpora albicantia. This has often led
to the statement that the equine ovary is “inverted” compared to other mammalian species.
Another unique feature of the equine ovary is that ovulation only occurs in one location, the
ovulation fossa [7]. The ovulation fossa is the only area of the mare ovary to be covered by
germinal epithelium, contrary to other species where germinal epithelium surrounds the entire
surface of the ovary [6,9].
The ovary houses oocytes contained within follicles in various stages of growth.
Primordial follicles, those present at birth which are arrested in meiosis until recruited, are
characterized by one layer of squamous cells surrounding the oocyte. During the estrous cycle, a
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cohort of primordial follicles will be recruited to grow. Early follicle growth (< 10 mm) appears
to occur independent of gonadotropins; however, progression of follicular growth is mostly
influenced by FSH. During a wave of follicular growth, primordial follicles will transition to
primary follicles, characterized by a single layer of cuboidal cells surrounding the oocyte.
Primary follicles advance to secondary follicles when two or more layers of cells are present
with no antrum. Tertiary, or Graafian, follicles are characterized by a fluid-filled antrum and
include three cell layers: theca externa, theca interna, and granulosa cell layer [7,8]. During this
wave, typically one follicle is selected for dominance in the mare and undergoes final maturation
and eventual ovulation under the influence of LH.
Ovulation is reliant on a surge of LH as a result of positive feedback from ovarian
estradiol. During the periovulatory period, steroidogenesis shifts from estradiol production to
progesterone production as granulosa cells differentiate into luteal cells. Granulosa cells
transform into large luteal cells while theca interna transform into small luteal cells, forming the
CL [5,7,8].
2.3. Estrous Cycle
The estrous cycle of the mare averages 21 days and is defined as the period from one
ovulation to the next. The estrous cycle is divided into two phases, the follicular phase and the
luteal phase, based on the primary structure(s) present on the ovary during that time. The
follicular phase is dominated by estradiol and is characterized by gonadotropin release, follicle
preparation for ovulation, sexual receptivity, and eventually ends with ovulation [6,7]. During
the follicular phase, progesterone is low and LH and FSH are secreted by the anterior pituitary.
Follicle stimulating hormone is required for emergence and initial growth of small follicles
[7,10]. Luteinizing hormone is responsible for final maturation of the dominant follicle and
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induction of ovulation at the end of the follicular phase [6,7]. The luteal phase immediately
proceeds and is characterized by formation of the CL, referred to as luteinization, synthesis and
secretion of progesterone by the luteal cells of the CL, and luteolysis. Luteolysis is initiated by
secretion of prostaglandin F2α (PGF2α) from the non-pregnant uterine endometrium 14-15 days
post-ovulation [6,11]. After luteolysis, blood progesterone decreases, signaling the end of the
luteal phase and the beginning of the follicular phase.
2.4. Seasonality
The mare is seasonally polyestrous, cycling only during the long-days of the year. This is
unique in that other seasonally cycling species, such as sheep and goats, cycle during the short
days of the year. The seasonal pattern of reproduction in the mare ensures she delivers a foal
during the spring. Thus, with an 11-month gestation period, it is necessary for reproductive
activity to cease during the winter months. The annual reproductive cycle of the mare can be
divided into four stages: the breeding season which occurs when the days are long, such as
spring and summer; the autumnal transition, when the mare transitions to a period of seasonal
anovulation, also referred to as seasonal anestrus, as the days begin to shorten; the non-breeding
season, in which the mare ceases to cycle during the short days of the year, occurring in the
winter months; and the vernal transition period as the days begin to lengthen in early spring,
which is characterized by erratic follicular activity with or without the occurrence of ovulation.
During the non-breeding season, mares can be clinically defined to be in deep anestrus if follicles
≤ 20 mm in diameter are present on the ovaries upon transrectal ultrasonography and plasma
progesterone levels are < 1.0 ng/mL [12].
Many equine breeding registries in the Northern Hemisphere have a set birthdate of
January 1st for foals born during that year. This sets an incentive for breeders to produce foals as

6

close to this universal birthdate as possible. Given the 11-month gestation period of the mare,
mares would need to be bred during February in order to produce foals in January, thus
promoting the manipulation of the breeding season.
2.5. Manipulation of the Breeding Season
The seasonal reproductive changes in long-day breeders are governed by changes in
daylength, as described before [11,13]. Therefore, manipulation of photoperiod is the most
utilized method to induce early cyclicity. Artificial lighting is typically supplied 60 days prior to
the start of the breeding season to induce early transition. Manipulating photoperiod by use of
artificial lights has been considered an effective way to advance the breeding season by up to two
months [14–16].
Exogenous hormonal therapies have also been utilized to induce early transition. The use
of exogenous GnRH or its analogues have had limited success in advancing the breeding season,
and repeated use can result in downregulation of GnRH receptors [17]. The use of progestogens,
in conjunction with other hormones, such as estrogen or human chorionic gonadotropin (hCG),
has some effectiveness with synchronization of estrous cycles and/or ovulation, but is limited in
the ability to hasten the onset of the breeding season during the transition period. Many hormonal
therapies are less effective if the mare is in deep anestrus. One exception is the use of dopamine
receptor antagonists, such as domperidone or sulpiride. They have been utilized to induce
ovulations during the anestrous season and/or vernal transition period with high success [18–20].
Sulpiride and domperidone have been utilized to stimulate prolactin secretion by blocking the
inhibitory action of dopamine on prolactin secretion. An even greater prolactin response is
achieved if the mare is pretreated with a conjugated estradiol [21,22]. Prolactin has been
observed to have roles in seasonal reproduction and the shedding of the winter coat of mares
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(reviewed by Thompson and Oberhaus [23]). There is a preovulatory prolactin surge in the mare,
suggesting the role prolactin has on the stimulation of ovulation [24]. Pretreatment with
estradiol, in the form of estradiol benzoate (EB) or estradiol cypionate (ECP), also stimulates LH
secretion, which enhances the response of stimulated prolactin secretion with dopamine
antagonists when administered to seasonally anestrous mares [21,22,25–28].
2.6. Kisspeptin
2.6.1. Brief History
In 1996, the Kiss1 gene was originally discovered as a suppressor of metastasis for
human malignant melanoma in Hershey, Pennsylvania, in which it was named after [29], and the
Kiss1-derived peptide was known as metastin [30]. In 2003, a reproductive role for kisspeptin
was assigned when a family of five siblings with isolated hypogonadotropic hypogonadism
(iHH) underwent a genome-mapping strategy. It was determined that inactivation of kisspeptin
receptor, G protein-coupled receptor 54 (GPR54), was the cause of iHH, and indicated that
GPR54 and kisspeptin play an important role in the regulation of the gonadotropic axis [31].
2.6.2. Overview
Kisspeptins are a family of peptides encoded by the Kiss1 gene. They are cleaved from a
prepropeptide 145 amino acids in length and include kisspeptin-54, 14, 13 and 10 [29,32]. All of
these peptides have a common C-terminus, Arg-Phe-NH2, characteristic of the RF-amide family.
Kisspeptin has natural ligands for the G protein-coupled receptor 54 (GPR54), encoded by the
Kiss1r gene [30,33]. The kisspeptin receptor, GPR54, is a seven transmembrane domain, Gq/11coupled receptor, and the effects of the receptor are stimulated through activation of
phospholipase C cell signaling pathway and result in the release of intracellular Ca2+ [33]. The
sequence for equine kisspeptin-10 is YRWNSFGLRY-NH2 [34].
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2.6.3. Kisspeptin Signaling in Reproduction
The neuropeptide kisspeptin has roles in sexual differentiation and timing of puberty
onset and is considered the key neuroendocrine gatekeeper for activation of the HP axis by direct
interaction with the kisspeptin receptor on GnRH neurons to stimulate GnRH release, which then
stimulates secretion of FSH and LH from the adenohypophysis [7,35–37]. Although the
distribution of kisspeptin neurons and its receptor varies depending on species, expression has
been identified in the arcuate nucleus (ARC), median eminence (ME), and preoptic area (POA)
or anteroventral periventricular nucleus (AVPV) of many species [38,39].
Besides the horse, other seasonally breeding species, such as the ewe and hamster, have
been investigated for the characterization of kisspeptin neuronal populations during different
reproductive stages/seasons as well as the effect of puberty on these populations [40–45].
Magee et al. [46] and Decourt et al. [47] provided neuroanatomical evidence that
kisspeptin neuron fibers directly contact GnRH neurons throughout the POA, ARC, and ME of
the mare hypothalamus. Decourt et al. [47] examined kisspeptin neuroanatomical interactions
with GnRH neurons right after (2 – 4 hours) ovulation and provided dual immunofluorescence
imaging of close appositions between kisspeptin fibers and GnRH fibers in the ME at the time of
the ovulatory LH surge in pony mares, as well as fluorescent imaging of a large population of
kisspeptin neurons distributed throughout the ARC. Magee et al. [46] examined kisspeptin
neuronal populations in the diestrous mare, and noted similar observations to Decourt et al. [47]
in regards to a large population of kisspeptin neurons in the ARC, but also observed large
clusters of kisspeptin neurons located in the POA. Magee et al. [46] observed that 33.7% of
kisspeptin fibers had close apposition to GnRH neurons, providing neuroanatomical evidence of
the kisspeptin/GnRH system in the mare hypothalamus. Magee et al. [34] also established
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evidence for kisspeptin directly affecting the pituitary in the mare by stimulating a rise in
intracellular Ca2+ in pituitary cells treated with equine kisspeptin-10 in vitro.
In the rat, kisspeptin neurons located in the AVPV mediate positive feedback action of
estradiol [35]. Kisspeptin neurons located in the ARC are hypothesized to mediate negative
steroidal feedback [42,48]. As mentioned before, estradiol from the maturing follicle provides
feedback to GnRH to signal the LH surge required for ovulation, but GnRH neurons do not
express estrogen receptor-alpha (ERα) [49] or progesterone receptors (PR) [50]. Kisspeptin
neurons have been found to express ERα [41] and PR [40]. It is hypothesized that kisspeptin
neurons located in the ARC regulate the pulsatility of GnRH (i.e., the tonic center) while the
kisspeptin neurons located in the POA are responsible for regulation of the LH surge (i.e., the
surge center) [51–53].
Matsui et al. [37] and Messager et al. [36] were some of the first to administer exogenous
kisspeptin to rats and sheep to elicit a rise in serum GnRH concentrations, and ovulation was
stimulated in rats pretreated with pregnant mare serum gonadotropin (PMSG). Although
exogenous administration of kisspeptin has been shown to induce ovulation in seasonally
anestrous ewes [54], it fails to induce ovulation in mares [46,55–58], likely due to the extended
LH surge that lasts for several days rather than hours compared to other species [11,56,59].
Decourt et al. [57] established the minimal effective dose to stimulate an increase in LH,
but failed to induce ovulation in the mare regardless of reproductive status or season [58].
Decourt et al. [58] also found that treatment with equine kisspeptin-10 was most effective at
stimulating an increase in LH and FSH during the early follicular phase, but still failed to hasten
the date to ovulation. Magee et al. [56] found that kisspeptin treatment post-ovulation had no
effect on progesterone secretion by the CL, but treatment with kisspeptin did have a negative
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effect on serum estradiol and sexual receptivity in estrous mares. McGrath et al. [55] was unable
to induce ovulation in mares during the vernal transition when given a constant rate of infusion
of kisspeptin. Interestingly, Briant et al. [60] was able to hasten the date to ovulation in
synchronized cycling Welsh pony mares when given an intravenous bolus injection of kisspeptin
when the dominant follicle was 33 mm in diameter, but Magee et al. [46] was unable to replicate
similar results. The results of Briant et al. [60] and Magee et al. [46] provide a comparison for
the use of kisspeptin to stimulate ovulation when a preovulatory-sized follicle is present, as
comparable to the use of GnRH analogues or hCG in similar circumstances [61].
Administration of native kisspeptin to mares is ineffective at stimulating ovulation in the
absence of preovulatory-sized follicle, regardless of season likely due to the unique
endocrinologic profiles of the horse and the inability of native kisspeptin to resist proteolytic
degradation. Kisspeptin analogs have been developed in an attempt to combat the rapid
proteolytic degradation and maintain stability and potency of the molecule. Analogs developed
include FTM080 [62,63], TAK-683[64,65], Compound 17 [66], and C6 [67]. Kisspeptin analog
C6 has been the most successful at inducing ovulation and advancing puberty in Ile de France
ewes [67,68], and can be used as an alternative to PMSG in the Alpine goat [69]. Fanelli et al.
[70] compared the ability of C6 to trigger ovulation in comparison to buserelin acetate, a GnRH
agonist, in jennies. While C6 was successful at triggering ovulation in the presence of a
preovulatory-sized follicle, similar to the effects of GnRH agonists, there is no current research
published assessing the effects of C6 during the nonbreeding season in jennies or mares.
Currently, administration of kisspeptin or kisspeptin analogs to mares to advance the breeding
season or trigger ovulation is considered unsuccessful.
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2.6.4. KNDy Neurons
A subpopulation of kisspeptin neurons located in the ARC, named KNDy neurons,
express the tachykinin neurokinin B (NKB) and the endogenous opioid peptide dynorphin (Dyn)
which cooperate in the regulation of the HP axis by combining steroidal and metabolic feedback
to GnRH neurons in the hypothalamus [71]. It has been suggested that the colocalization of Dyn
and kisspeptin mediates progesterone negative feedback, and that the colocalization of NKB with
kisspeptin mediates positive feedback actions of estradiol [42]. Goubillon et al. [72] investigated
that the majority of NKB neurons in the ovine ARC expressed ERα. Foradori et al. [73]
investigated a similar distribution of Dyn neurons in the ovine ARC with most of them
expressing progesterone receptors. These key findings led to the possibility of both NKB and
Dyn being contained within the same neurons [74,75].
2.6.5. Kisspeptin in the Gonads
Kisspeptin and/or its receptor localization has been characterized in the gonads of many
species, including horse testes [2]; cat ovary [76]; canine ovary [77]; Siberian Hamster ovary
[45]; human and marmoset ovaries [78]; rat ovary [79]; swine ovary [80]; buffalo ovary [81–83];
and chicken ovarian cells [84]. Recently, Petrucci et al. [2] evaluated the kisspeptin/GnRH1
system in the Leydig cells of horse testes via immunohistochemistry (IHC) and found
immunopresence of kisspeptin and its receptor in Leydig cells, providing evidence for the
kisspeptin/receptor system at the level of the gonads in the horse. Immunocytochemistry of in
vitro cultured granulosa cells from chicken ovary revealed immunosignal for kisspeptin-10 [84].
In the rat ovary [79], the pattern of kisspeptin staining was affected by reproductive stage
and cell type. Kisspeptin immunosignal was present in the oocyte and thecal cells of growing and
preovulatory follicles throughout the estrous cycle, but there was no evidence of signal in
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granulosa cells of the same follicles. Ovarian surface epithelium (OSE) and developing CL
presented positive immunolabeling for kisspeptin. Kisspeptin receptor immunolabeling had a
similar pattern of staining to kisspeptin in growing and preovulatory follicles and CL [79].
In the human and marmoset ovaries [78], kisspeptin immunosignal was detected in theca
cells of developing follicles, luteal cells of the CL, and the OSE. This is similar to the
observation made by Castellano et al. [79] in the rat ovary. Kisspeptin receptor immunostaining
patterns in the human ovary are similar to that of kisspeptin, except there was no reported
staining in the OSE for receptor. Kisspeptin receptor immunolocalization was not assessed in
marmoset ovary in this study [78].
The hamster provides a model for long-day seasonal breeders, like the horse. Shahed and
Young [45] characterized kisspeptin and receptor immunolocalization in cycling Siberian
hamster ovaries throughout each phase of the reproductive cycle and during a photoperiod
induced recrudescence. Immunostaining for kisspeptin and its receptor were localized to
steroidogenic cells of preantral and antral follicles throughout the estrous cycle and steroidogenic
cells of the CL. In contrast to the rat [79] and human [78] studies, in which kisspeptin and/or
receptor immunoreactivity was not present in granulosa cells follicles. Staining was most intense
during proestrus and estrus of the cycle, and staining decreased during diestrus. During the
photoperiod induced recrudescence, intensity of immunostaining for kisspeptin and its receptor
increased which suggests a role for kisspeptin and its receptor in restoring ovarian function [45].
In the canine ovary [77], kisspeptin and its receptor were localized in all oocytes in prepubescent, cycling, and anestrous females and the CL of cycling ovaries. Immunostaining for
kisspeptin was present in granulosa cells of follicles in cycling ovaries. Kisspeptin receptor
immunoreactivity was present in granulosa cells of follicles in cycling, anestrous, and pre-
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pubescent ovaries. Similar to the Siberian hamster [45], staining was present for both kisspeptin
and receptor in granulosa cells of the follicle, in contrast to the rat [79] and human [78] studies.
In domestic cat ovaries [76], kisspeptin and receptor immunostaining was present
throughout all stages of the cycle with no differences in cell types throughout each stage of the
cycle. Kisspeptin and receptor immunoreactivity were present in the oocyte, granulosa cells, and
theca cells of follicles and the CL. Kisspeptin staining was also present in follicular fluid of
antral follicles. Tanyapanyachon et al. [76] suggest that the kisspeptin/kisspeptin receptor system
may have a role in folliculogenesis and oocyte survival.
Kisspeptin and its receptor localization has been characterized in the buffalo (Bubalus
bubalis) ovary [81–83]. Mishra et al. [82,83] assessed immunofluorescence signal for kisspeptin
and receptor in the cyclic CL and observed intense signal during the early and middle stage CL,
but weak signal was observed in the late CL. Rajin et al. [81] assessed the pattern of kisspeptin
and receptor staining throughout follicles of different functional status (i.e., active, intermediate,
atretic). Immunostaining for kisspeptin and receptor was present in granulosa cells of active and
intermediate follicles, but kisspeptin immunostaining was present in theca interna cells of active
follicles only.
Basini et al. [80] characterized the localization of kisspeptin and its receptor in swine
ovaries. Intense kisspeptin and receptor immunostaining was present in the granulosa cells of
preantral and antral follicles, but staining was less obvious in theca cells of the same follicles
observed. In the same preantral and antral follicles, kisspeptin and receptor immunostaining was
observed in the zona pellucida surrounding the oocyte and the oocyte cytoplasm.
Although the pattern of kisspeptin and kisspeptin receptor immunostaining varies
depending on species, reproductive cycle stage, and cell type, the presence of kisspeptin and
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receptor staining in the ovaries of many species suggests that kisspeptin may have a role in
regulating the HPO axis at the level of the ovary or ovarian follicle development.
2.7. Rationale for Present Experiment
Kisspeptin and its receptor have been implicated in the seasonality of reproduction in the
mare, but much is still unknown regarding the physiological roles at the level of the ovary. The
aim of this study was use standard immunohistochemical procedures to evaluate and localize
kisspeptin and kisspeptin receptor staining in mare ovaries and compare the pattern of
immunostaining between follicle sizes and reproductive states.
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CHAPTER 3. MATERIALS AND METHODS
3.1. Ovary collection
A single ovary from 11 mares was used for immunohistochemistry, including three
follicular phase ovaries, two luteal phase ovaries, three anestrous ovaries, and three ovaries from
ECP-sulpiride treated mares in winter. Follicular and luteal phase ovaries were collected postmortem in June and July. Follicular phase ovaries were defined as cycling ovaries lacking active
luteal structures with follicles greater than or equal to 25 mm. Luteal phase ovaries were defined
as cycling ovaries with active luteal structure(s) present. Corpora albicantia were not considered
active luteal structures.
3.1.1. Treatment with estradiol cypionate and sulpiride
As part of a larger, separate experiment, deep anestrous mares were treated with 50 mg
ECP one day prior to treatment with 3 g sulpiride, both intramuscularly. One ovary was collected
from each of three treated mares once a follicle ≥ 30 mm was detected by ultrasonography.
Standing colpotomy was achieved using a chain ecrassuer after sedation. Each day an ovary from
a treated mare was collected, an ovary from an untreated, deep anestrous mare was also collected
in the same manner. Mares were determined to be in deep anestrus if follicles ≤ 20 mm in
diameter are present on the ovary upon transrectal ultrasonography and plasma progesterone
levels were < 1.0 ng/mL [12].
3.2. Tissue preparation
Ovaries were bisected longitudinally at the midline through the ovulation fossa. One half
of each ovary was immediately immersed in 10% neutral buffered formalin for transport.
Ovarian sections were further bisected creating three or four sections per hemi-ovary before
further fixation in 4% paraformaldehyde. Sections were processed by dehydration in ethanol
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(EtOH) and embedded in paraffin. Paraffinized tissue blocks were cut at 5 m using a microtome
and mounted onto positively charged slides.
3.3. Immunohistochemistry
Mounted sections were deparaffinized in two changes of xylene for 3 minutes each,
transferred to a solution of xylene with 100% EtOH (1:1) for 3 minutes, then two changes of
100% EtOH for 3 minutes each, then 95% EtOH for 3 minutes, then 70% EtOH for 3 minutes,
then 50% EtOH for 3 minutes, and then rinsed in deionized water. For antigen retrieval, tissue
sections were steamed in Na Citrate buffer (10 mM, pH 6) solution using a rice cooker at 95℃
for 20 minutes and allowed to cool on ice for 20 minutes. Tissues were then rinsed in deionized
water for 5 minutes. To quench endogenous peroxidase activity, slides were immersed in 0.3%
H2O2 and methanol for 30 minutes at 23℃ and then rinsed in deionized water for 5 minutes.
Tissue was rinsed again in tris-buffered saline (TBS) containing 0.3% Triton X-100 (TBSt) for 5
minutes. Background labelling was prevented by incubating tissue sections with 1.5% (v/v)
normal goat serum (NGS) for 30 minutes at 23℃ and then lightly shaken to remove serum.
Tissues were incubated with either anti-Kiss1r polyclonal rabbit antibody diluted 1:100 (AKR001; Alomone Labs, Jerusalem, Israel) or anti-Kp10 polyclonal rabbit antibody diluted 1:200
(AB9754-I; Millipore, Massachusetts, USA) at 23℃ for one hour and then at 4℃ overnight.
Hypothalamus tissue from a mare served as positive control for validation of both antibodies.
Primary antibodies were diluted in TBSt containing 1.5% NGS. Primary antibodies were omitted
from negative control tissues and were instead incubated with TBSt containing 1.5% NGS.
Tissues were rinsed three times in TBSt for 5 minutes each and incubated in biotinylated goat
anti-rabbit IgG secondary antibody (PK-6101; Vector Laboratories, Burlingame, CA, USA) for
one hour at 23℃. Tissues were rinsed again in TBSt three times for 5 minutes each and then
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incubated in avidin-biotin complex (Vectastain Elite ABC Kit; Vector Laboratories, Burlingame,
CA, USA) for one hour at 23℃. Tissues were then rinsed once with TBS for 5 minutes.
Immunolabelling was visualized by incubating tissues with diaminobenzidine solution
(ImmPACT DAB Peroxidase Substrate; Vector Laboratories, Burlingame, CA, USA) for 15
minutes. Slides were rinsed once with deionized water and then counterstained with Mayer`s
hematoxylin for 1 minute. Slides were rinsed with deionized water for 5 minutes and then
dehydrated and cleared by transferring to 70% EtOH for 3 minutes, then 80% EtOH for 3
minutes, then 95% EtOH for 3 minutes, then two changes of 100% EtOH for 3 minutes each, and
then two changes of xylene for 3 minutes each. Slides were mounted with coverslips using a
xylene-based mounting medium (Eukitt; Sigma, St. Louis, MO, USA).
3.3. Evaluation and Statistical Analysis
A single observer assessed immunostained slides using a light microscope at 200x. A
minimum of 30 follicles from each developmental category, or every structure in that category
found on the ovary where fewer than 30 were present, were assessed from each ovary. A total of
1,244 follicles were observed for Kp10 staining and 1,258 follicles observed for Kiss1r staining.
All follicles were counted and graded for staining intensity using a scale of 0-3. A scoring
system of 0–3 was used in which 0 described no staining or staining equivalent to background
staining and 3 described intense staining. Corpora lutea were also visualized and graded based on
staining density.
Staining intensity was compared between different follicle sizes within a reproductive
state as well as between reproductive states using two-way ANOVA (GraphPad Prism version
8.0.0 for Windows; GraphPad Software, San Diego, CA). Follicle size served as one factor and
reproductive state as a second factor. Parametric tests were chosen based on determination of a
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normal distribution for all data sets. Significance was determined if P ≤ 0.05 and, if significant,
means were separated using Tukey`s test.
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CHAPTER 4. RESULTS
4.1. Staining intensity of kisspeptin-10 and kisspeptin receptor
Equine hypothalamus was used as positive control tissue for validation of anti-Kp10
(panel A) and anti-Kiss1r (panel B) antibodies, as shown in Figure 4.1 with immunosignals
present in neurons near the III ventricle of the hypothalamus.

A

B

C

Figure 4.1. Hypothalamus tissue from a mare was used as a positive control for both kisspeptin10 and kisspeptin receptor antibodies. Omission of antibody (panel A) from hypothalamus tissue
served as negative control. Panels B and C represent positive staining for kisspeptin-10 and
kisspeptin receptor, respectively. Scale bars represent 50 μm.

A total of 1,244 follicles were assessed for Kp10 immunoreactivity and 1,258 follicles
were assessed for Kiss1r immunoreactivity. Positive immunostaining of Kp10 and Kiss1r was
present throughout reproductive structures in the mare ovary, including all follicle types and
corpora lutea. Regardless of reproductive state, intensity of Kp10 and Kiss1r staining increased
as follicle size increased (P < 0.0001 and P < 0.0001, respectively). An interaction (P < 0.01)
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between follicle size and reproductive state was also observed for Kiss1r staining. The intensity
of staining was affected by follicle size and reproductive state.

4.2. Differences in kisspeptin-10 staining intensity in follicles within different reproductive
states
Mean kisspeptin-10 staining intensity between follicle sizes within different reproductive
states is presented in Figure 4.2. In primordial follicles, staining was most intense and similar in
ovaries from follicular phase mares and mares stimulated with ECP-sulpiride. Staining in
primordial follicles was least intense in ovaries from luteal phase mares and differed (P < 0.01)
from all other reproductive states. Staining in primordial follicles from anestrous mares was less
(P < 0.001; Figure 4.3.) than ECP-sulpiride treated mares but did not differ from follicular phase
mares.
Staining intensity in preantral follicles was least in luteal phase ovaries and differed (P ≤
0.05; Figure 4.2.) from anestrous ovaries and ovaries from mares stimulated with ECP-sulpiride.
Staining intensity in preantral follicles tended to be less (P ≤ 0.1) in luteal phase ovaries
compared to follicular phase ovaries. Figure 4.4 illustrates staining observed in anestrous ovaries
and ovaries from mares stimulated with ECP-sulpiride.
Staining for Kp10 was most intense in antral follicles and did not differ between
follicular, luteal, or ECP-sulpiride stimulated ovaries; however, staining intensity tended to be
less (P = 0.06) in anestrous ovaries compared to follicular and ECP-sulpiride stimulated ovaries.
Figure 4.5 illustrates staining observed in luteal and follicular phase ovaries.
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Figure 4.2. Mean staining intensity for kisspeptin in primordial (panel A), preantral (panel B)
and antral (panel C) follicles within different reproductive states. Means with different
superscripts within a panel differ at P ≤ 0.05. Superscripts with * denotes differences at P < 0.1.

A

B

Figure 4.3. Kisspeptin immunostaining in primordial follicles of anestrous ovaries (panel A) and
ovaries from mares stimulated with estradiol cypionate and sulpiride (panel B). Omission of
primary antibody served as a negative control (inserts). Scale bars are 50 μm.

22

A

B

Figure 4.4. Kisspeptin immunostaining in preantral follicles of anestrous ovaries (panel A) and
ovaries from mares stimulated with estradiol cypionate and sulpiride (panel B). Omission of
primary antibody served as a negative control (inserts). Scale bars are 50 μm.

B

A

Antrum

Antrum

Figure 4.5. Kisspeptin immunostaining in antral follicles of luteal phase ovaries (panel A) and
follicular phase ovaries (panel B). Single arrow illustrates staining in granulosa cells while
double arrow illustrates staining in theca cells. Omission of primary antibody served as a
negative control (inserts). Scale bars are 50 μm.
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4.3. Kisspeptin receptor staining intensity between follicle sizes within different
reproductive states
Mean kisspeptin receptor staining intensity between follicle sizes within different
reproductive states is presented in Figure 4.6. In primordial follicles, staining was most intense in
ovaries from mares stimulated with ECP-sulpiride and was greater (P < 0.01) compared to all
other reproductive states. Figure 4.7 illustrates staining observed in primordial follicles within
anestrous ovaries and ovaries from mares stimulated with ECP-sulpiride.

Figure 4.6. Mean staining intensity for kisspeptin receptors in primordial (panel A), preantral
(panel B) and antral (panel C) follicles within different reproductive states. Means with different
superscripts within a panel differ at P ≤ 0.05. Superscripts with * denotes differences at P < 0.1.
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A

B

Figure 4.7. Kisspeptin receptor immunostaining in primordial follicles of anestrous ovaries
(panel A) and ovaries from mares stimulated with estradiol cypionate and sulpiride (panel B).
Omission of primary antibody served as a negative control (inserts). Scale bars are 50 μm.

In preantral follicles, staining was similar between follicular, luteal and ECP-sulpiride
stimulated ovaries. Staining was less (P < 0.01) in luteal phase ovaries compared to follicular
phase ovaries but did not differ from anestrous or ECP-sulpiride stimulated ovaries.
Kisspeptin receptor staining intensity in antral follicles was less (P ≤ 0.01) in anestrous
ovaries compared to follicular phase ovaries and tended (P = 0.07) to be less than ECP-sulpiride
stimulated ovaries. Staining in antral follicles was similar between follicular, luteal and ECPsulpiride stimulated ovaries. Figure 4.8 illustrates kisspeptin receptor staining observed in an
antral follicle of luteal and follicular phase ovaries.
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A

B
Antrum

Antrum
Antrum

Figure 4.8. Kisspeptin receptor immunostaining in antral follicles of luteal phase ovaries (panel
A) and follicular phase ovaries (panel B). Single arrow illustrates staining in granulosa cells
while double arrow illustrates staining in theca cells. Omission of primary antibody served as a
negative control (inserts). Scale bars are 50 μm.

4.5. Other Immunoreactive Tissues
When present, corpora lutea were assessed for presence or absence of staining but were
not graded. Figure 4.9 illustrates the positive immunostaining for both Kp10 and Kiss1r. Staining
was uniform throughout luteal cells and there were no subjective differences in staining pattern
of CL observed.
The germinal epithelium of the ovulation fossa stained positive for kisspeptin and
receptor. Oocytes also stained positive for both kisspeptin and receptor in primordial, preantral,
and early antral follicles. Staining intensity of the oocyte was dependent on the staining intensity
of the surrounding cells of the respective follicle. Oocytes in late antral follicles were not present
in sections processed for IHC.
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A

B

Figure 4.9. Positive immunostaining for kisspeptin-10 (panel A) and kisspeptin receptors (panel
B) in luteal cells. Omission of primary antibodies served as negative controls (insert). Scale bars
are 50 μm.
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CHAPTER 5. DISCUSSION
The role(s) of the kisspeptin and kisspeptin receptor system in mammalian reproduction
at the level of the hypothalamus has been well established; however, extrahypothalamic actions
of kisspeptin have been investigated. Peripheral actions of kisspeptin/Kiss1r have been explored
as regulators of uterine and placental function, particularly in trophoblast migration,
implantation, and placentation as reviewed by Gomes and Sones [85]. Kisspeptin and its cognate
receptor have been identified in the gonads of several species including the ovaries of rats [79],
hamsters [45], humans and marmosets [78], cats [76], dogs [77], pigs [80], and buffalos [81–83].
Pattern and intensity of staining for both peptides varies between studies and appears to be
species dependent. In the horse, kisspeptin and Kiss1r were immunolocalized in Leydig cells of
the testes [2]. Corresponding transcripts were also found, indicating the possibility of de novo
synthesis [2]. Furthermore, kisspeptin expression has been found in the endometrium and
embryonic tissues of pregnant mares (unpublished).
The present study is the first to compare immunostaining for kisspeptin and its receptor
between follicle sizes and reproductive states. McGrath [86] observed kisspeptin
immunoreactive staining in the cells of some preantral follicles, as well as in the largest antral
follicle in an ovary from a mare in vernal transition, but no comparisons were made in that study
as immunostaining was not the primary objective. In the present study, regardless of
reproductive state, intensity of staining for both peptides increased as follicle size increased. This
may indicate a role for kisspeptin/Kiss1r in late-stage follicular growth, maturation, and/or
ovulation. In mares, immunostaining for Kp10 was least intense in primordial follicles of luteal
and anestrous phase ovaries and was most intense in antral follicles of follicular phase ovaries
and ovaries from mares treated with ECP-sulpiride. In rats and hamsters, expression of
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kisspeptin peaks in the afternoon during proestrus, also providing evidence that kisspeptin may
be involved in ovulatory events [45,79]. Immunostaining for Kiss1r was least intense in
primordial follicles of follicular and luteal phase ovaries and was most intense in antral follicles
of follicular phase ovaries and ovaries from mares treated with ECP-sulpiride.
These findings are consistent with other findings in swine ovarian follicles [80], in which
immunostaining for kisspeptin and receptor were present in preantral and antral follicles with
intense staining in granulosa cells and less intense, but still present, staining in theca cells. This
contrasts with human and marmoset [78] and rat [79] studies in which immunostaining for
kisspeptin and its receptor were minimal or absent in granulosa cells but were present in theca
cells and the luteal cells, similar to the current findings and other species, such as the buffalo
[81].
In the canine ovary [77], immunoreactive staining pattern is consistent with the findings
of the current study except for the absence of staining for kisspeptin and its receptor in theca
cells of follicles. In the mare, staining for both peptides was present in theca cells, albeit weaker
than neighboring granulosa cells. No kisspeptin immunosignal was detected in granulosa cells of
anestrous bitches; however, Kiss1r immunosignal was consistent across all reproductive states,
including anestrus [77]. This differs from the present study where kisspeptin was detected in
granulosa cells of anestrous ovaries, although weaker than cycling or stimulated granulosa cells.
Canine oocytes consistently stained for kisspeptin and its receptor, regardless of reproductive
state [77]. This may indicate a role for kisspeptin in the bidirectional communication between
developing oocytes and surrounding granulosa cells.
Kisspeptin as an oocyte maturation factor has been largely explored [87–92]. In rats,
Kiss1r expression is predominantly in oocytes, while kisspeptin expression is largely expressed
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in granulosa cells [92]. Chakravarthi et al. [89] further identified expression of Kiss1r in oocytes,
but not in granulosa cells. Furthermore, oocytes derived from wild-type and estrogen receptor 
() null rats were supplemented in vitro with Kp10. Expression of both growth and
differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15), two proteins
secreted by oocytes and highly correlated with oocyte maturation, were upregulated [89].
Interestingly, bone morphogenetic protein 7 (BMP7), a protein implicated in facilitating the
transition from primordial to primary follicle, was downregulated by Kp10 [89]. Upregulation of
c-mos, an oncoprotein required for meiosis, has also been observed in oocytes matured in the
presence of kisspeptin; however, FSH was critical to the permissive actions of kisspeptin as it did
induce a significant increase in oocyte expression of Kiss1r [91]. Resumption of meiosis is a
critical event in oocyte maturation. A remarkable increase in kisspeptin expression has been
observed in mouse oocytes around the time of meiotic resumption [91], suggesting that perhaps
kisspeptin is involved in the ability to undergo meiosis. Taken together, a great case can be made
for a role for kisspeptin and its receptor in oocyte maturation. Further gene expression studies are
needed to determine expression levels in equine ovarian cells.
In the domestic cat ovary [76], immunoreactive staining patterns of kisspeptin and
receptor are consistent with the findings of the current study except for the absence of staining
for kisspeptin receptor in the granulosa cells of antral follicles but presence of stain in theca cells
of the same follicles. In the present study, there were no instances of kisspeptin or receptor
staining present in only theca cells of follicles and absent in granulosa cells of the same follicles,
although some antral follicles exhibited greater staining intensity in granulosa cells compared to
theca cells of the same follicle, similar to the findings of Tanyapanachon et al. [76] and Santos et
al. [93]. Increased staining intensity in granulosa cells for kisspeptin and receptor indicate the
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potential for granulosa cells to be a site for kisspeptin synthesis in the follicle. In this study,
preliminary gene expression analysis revealed Kp10 transcripts in granulosa cells, luteal cells,
and ovarian stroma of mares (data not presented). Staining for kisspeptin and receptor was
present in all follicle types in the domestic cat ovary [76], similar to current findings, suggesting
a potential role for kisspeptin in follicular development throughout gonadotropin-independent
and gonadotropin-dependent stages of follicular growth.
The hamster and ewe provide models for assessing the role of kisspeptin in mediating
photoperiodic signals to the HPO axis [41,89,91,94]. The Siberian hamster, a long-day breeder
like the horse, provided the first model for characterizing kisspeptin immunoreactivity in a
seasonally breeding species at the ovarian level [45]. Kisspeptin and receptor immunostaining
was characterized throughout the estrous cycle as well as during photoperiod induced
recrudescence. Staining intensity varied depending on stage of the cycle, similar to current
findings, with a noticeable increase in staining intensity during the period of recrudescence
compared to the anestrous period, implicating potential roles for kisspeptin in the resumption of
ovarian activity [46]. Seasonally anestrous mares induced to cycle early with ECP-sulpiride
provided an opportunity to assess immunosignals in a recrudesced state. Obvious increases in
Kp10 staining intensity were observed in primordial and antral follicles of ECP-sulpiride treated
mares compared to seasonally anestrous mares. Kisspeptin receptor staining was also greater in
primordial and antral follicles of ECP-sulpiride treated mares. Staining intensities for both
peptides was similar between follicular phase ovaries and ovaries from ECP-stimulated mares
suggesting that treatment with ECP-sulpiride restored ovarian kisspeptin activity to a follicular
phase-like state. Without more quantitative analyses, such as gene expression, it cannot be
definitely concluded that this is the case. In a recent study by Bailey et al. [3], incorporation of
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Kp10 into treatment with EB-sulpiride resulted in more mares ovulating early compared to mares
receiving EB-sulpiride only. Whether the action of Kp10 was at the level of the ovary or via
enhanced endocrine responses from HP axis could not be concluded from that study. The finding
that staining intensity for both peptides was greater in ECP-sulpiride stimulated mares compared
to seasonally anestrous mares was significant as research continues to explore the mechanisms
by which the mare transitions into and out of cyclicity. Kisspeptin/Kiss1r may be involved in the
recrudescence of ovarian activity in the seasonally anestrous mare.
Immunopositive signals for both Kp10 and Kiss1r were observed in luteal cells with no
observed differences in intensities between large and small luteal cells. This is similar to findings
in the buffalo [81] and Siberian hamster [45]. However, further studies are needed to assess the
differences in kisspeptin and receptor immunoreactivity throughout different stages of luteal
development, such as CL formation, maintenance, and regression to determine relative
significance of kisspeptin in the mare CL. The presence of kisspeptin transcripts and kisspeptin
immunoreactive staining in the CL of most mammalian species studied to date indicates that
kisspeptin may have potential roles in CL formation and/or regression by similar means of the
proposed pathways of ovarian tissue remodeling leading up to ovulation, as proposed by
Castellano et al. [79]. The kisspeptinergic system may also play a role in the stimulation of
progesterone secretion as evidenced by an in vitro study of cultured rat luteal cells treated with
kisspeptin [95].
In vitro culture of rat luteal cells treated with kisspeptin resulted in stimulation of
progesterone secretion [95]. Granulosa cells cultured from swine ovarian follicles demonstrated
increased progesterone secretion and decreased/inhibited estradiol secretion when treated with
kisspeptin in vitro [80]. Both human [94] and porcine [80] cultured granulosa cells treated with
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Kp10 and FSH demonstrated that kisspeptin supports the stimulatory actions of FSH on cell
viability, proliferation, and estradiol and progesterone output. Transcripts of key steroidogenic
enzymes such as StAR, CYP11A and 3−HSD are also upregulated in rat luteal cells [95] and
chicken granulosa cells [84] cultured with Kp10, providing further evidence of the steroidogenic
promoting activity of kisspeptin.
Follicular fluid kisspeptin has been measured in some species [4,91] and positively
correlates with number of oocytes in women undergoing assisted reproductive technologies [4].
In this study, follicular fluid of antral follicles demonstrated positive immunostaining for
kisspeptin; however, without quantitative measurement, these results are tenuous. Additional
staining was observed in the ovulation fossa, although no semi-quantitative assessments were
attempted.
The findings of the present study provide evidence that the kisspeptinergic system exists
within the equine ovary and changes in relation to follicle size as well as reproductive state.
Based on semi-quantitative staining intensity, kisspeptin and its cognate receptor are more
abundant in antral follicles of cycling ovaries. The presence of kisspeptin and its receptor in the
oocyte and steroidogenic cells of follicles and CL indicate that kisspeptin may have roles in
oocyte maturation, follicular development, steroidogenesis, and/or ovulation. Variations in
staining patterns indicate potential roles for the kisspeptin/receptor system in ovulation, as
reported in other species. Further functional studies are needed in the horse to assess regulatory
roles of kisspeptin in ovarian steroidogenesis, as well as follicular development and oocyte
maturation.
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SUMMARY AND CONCLUSIONS
In conclusion, the present study is the first to localize Kp-10 and Kiss1r in equine
ovaries. Staining was present for both Kp-10 and Kiss1r in all follicle types across all stages, as
well as oocytes and CL. The most intense staining for Kp-10 and Kiss1r occurred in antral
follicles of ovaries from mares treated with ECP-sulpiride and follicular phase ovaries.
Compared to the decreased staining intensities in anestrous ovaries, this suggests that the
kisspeptin/receptor system may have potential roles in follicular growth leading up to ovulation.
Further research is needed to elucidate the modulatory mechanisms of kisspeptin on ovarian
steroidogenesis and follicular development in the horse model.
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